Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Iwuji, Collins C ^a,b   Churchill, Duncan ^a   Gilleece, Yvonne ^a   Weiss, Helen A ^c   Fisher, Martin ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

CD4 cell count; HIV; Late presentation; Mortality; Older adults

Indexed keywords

AGED; ARTICLE; ATTITUDE TO HEALTH; BLOOD; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DELAYED DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MORTALITY; STATISTICS; UNITED KINGDOM;

AGED; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DELAYED DIAGNOSIS; FEMALE; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 84876690560     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-397     Document Type: Article

References (49)

1. Health Protection Agency, HIV in the United Kingdom 2011 Report. 2011
2. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. May M, AIDS 2007 21 9 1185 1197 17502729 (Pubitemid 46763289)
3. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. Emery S, J Infect Dis 2008 197 8 1133 1144 18476292 (Pubitemid 351590049)
4. CD4+ count-guided interruption of antiretroviral treatment. El-Sadr WM, N Engl J Med 2006 355 22 2283 2296 17135583 (Pubitemid 44837777)
5. Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count >350 × 10(6)/l. Opravil M, AIDS 2002 16 10 1371 1381 10.1097/00002030-200207050-00009 12131214 (Pubitemid 34722069)
6. Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. Phillips AN, AIDS 2007 21 13 1717 1721 17690569 (Pubitemid 47237558)
7. Newly diagnosed HIV infections: review in UK and Ireland. Sullivan AK, BMJ 2005 330 7503 1301 1302 10.1136/bmj.38398.590602.E0 15894552 (Pubitemid 40813561)
8. Late diagnosis of HIV in Europe: definitional and public health challenges. Adler A, Mounier-Jack S, Coker RJ, AIDS Care 2009 21 3 284 293 10.1080/09540120802183537 19031304
9. Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. Burns FM, AIDS 2008 22 1 115 122 10.1097/QAD.0b013e3282f1d4b6 18090399 (Pubitemid 350294885)
10. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Lanoy E, Antivir Ther 2007 12 1 89 96 17503752 (Pubitemid 46340430)
11. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. Sabin CA, AIDS 2004 18 16 2145 2151 10.1097/00002030-200411050-00006 15577647 (Pubitemid 39463679)
12. CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. Stohr W, HIV Med 2007 8 3 135 141 10.1111/j.1468-1293. 2007.00443.x 17461856 (Pubitemid 46915683)
13. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. Castilla J, AIDS 2002 16 14 1945 1951 10.1097/00002030-200209270-00012 12351955
14. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. Wolbers M, HIV Med 2008 9 6 397 405 10.1111/j.1468-1293.2008.00566.x 18410354 (Pubitemid 352015643)
15. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. Klein D, J Acquir Immune Defic Syndr 2003 32 2 143 152 10.1097/00126334-200302010-00005 12571523 (Pubitemid 36222715)
16. Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Manavi K, Int J STD AIDS 2004 15 12 811 814 10.1258/0956462042563585 15601487 (Pubitemid 40018705)
17. The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. Krentz HB, Auld MC, Gill MJ, HIV Med 2004 5 2 93 98 10.1111/j.1468-1293.2004.00193.x 15012648 (Pubitemid 38404662)
18. HIV transmission and high rates of late diagnoses among adults aged 50 years and over. Smith RD, AIDS 2010 24 13 2109 2115 10.1097/QAD.0b013e32833c7b9c 20616697
19. Late presenters in an HIV surveillance system in Italy during the period 1992-2006. Borghi V, J Acquir Immune Defic Syndr 2008 49 3 282 286 10.1097/QAI.0b013e318186eabc 18845959
20. Definition and epidemiology of late presentation in Europe. Johnson M, Sabin C, Girardi E, Antivir Ther 2010 15 Suppl 1 3 8 10.3851/IMP1522 21041899
21. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. Gazzard BG, HIV Med 2008 9 8 563 608 10.1111/j.1468-1293.2008.00636.x 18826546
22. Late presentation of HIV infection: a consensus definition. Antinori A, HIV Med 2011 12 1 61 64 10.1111/j.1468-1293.2010.00857.x 20561080
23. Late presentation for HIV diagnosis and care in Germany. Zoufaly A, HIV Med 2012 13 3 172 181 22093171
24. Late presentation of HIV infection among adults in New Zealand: 2005-2012. Dickson NP, HIV Med 2012 13 3 182 189 22093231
25. National Research Ethics Service, Does my project require review by a Research Ethics Committee? [cited 2012 09 October 2012]; Available from: http://www.nres.nhs.uk/applications/approval-requirements/ethical-review- requirements/
26. Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Helleberg M, Scand J Infect Dis 2012 44 4 282 288 10.3109/00365548.2011.626440 22066814
27. Late presentation to care for HIV infection in Croatia and the effect of interventions during the Croatian Global Fund Project. Begovac J, AIDS Behav 2008 12 4 Suppl 48 S53 18459042
28. Correlates of late HIV diagnosis: implications for testing policy. Delpierre C, Int J STD AIDS 2007 18 5 312 317 10.1258/095646207780749709 17524190 (Pubitemid 351739001)
29. HIV testing in acute general medicine admissions must be universally offered to reduce undiagnosed HIIV. Perry N, HIV Medicine 2010 11 Supp.1 7 8
30. Late diagnosis of HIV infection: major consequences and missed opportunities. Fisher M, Curr Opin Infect Dis 2008 21 1 1 3 10.1097/QCO. 0b013e3282f2d8fb 18192778
31. HIV infection in older patients in the HAART era. Grabar S, Weiss L, Costagliola D, J Antimicrob Chemother 2006 57 1 4 7 16284223 (Pubitemid 43057052)
32. HIV infection and advanced age emerging epidemiological, clinical, and management issues. Manfredi R, Ageing Res Rev 2004 3 1 31 54 10.1016/j.arr.2003.07.001 15164725 (Pubitemid 38177437)
33. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. Girardi E, Sabin CA, Monforte AD, J Acquir Immune Defic Syndr 2007 46 Suppl 1 3 S8 10.1097/01.qai.0000286597.57066. 2b 17713423 (Pubitemid 47312320)
34. Health Protection Agency, HIV in the United Kingdom 2012 Report. 2012
35. Missed opportunities for diagnosing primary HIV infection. Sudarshi D, Sex Transm Infect 2008 84 1 14 16 10.1136/sti.2007.026963 17971369 (Pubitemid 351195843)
36. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. Sabin CA, AIDS 2006 20 1 67 71 10.1097/01.aids.0000196178.73174.24 16327321 (Pubitemid 41818116)
37. National review of deaths among HIV-infected adults. Lucas SB, Curtis H, Johnson MA, Clin Med 2008 8 3 250 252 18624028 (Pubitemid 351960975)
38. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Sobrino-Vegas P, Curr HIV Res 2009 7 2 224 230 10.2174/157016209787581535 19275591
39. Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. Smit C, PLoS One 2008 3 4 1949 10.1371/journal.pone.0001949 18398473 (Pubitemid 351984397)
40. Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed people. Delpierre C, Eur J Public Health 2008 18 3 345 347 10.1093/eurpub/ckm117 18070812 (Pubitemid 351786632)
41. Age as a determinant of survival in HIV infection. Babiker AG, J Clin Epidemiol 2001 54 16 21 10.1016/S0895-4356(01)00456-5 (Pubitemid 34013687)
42. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 2000 355 9210 7 1131
43. Revised recommendations for HIV of adults, adolescents and pregnant women in health care settings. Centers for Disease Control and Prevention, MMWR-Morbidity & Mortality Weekly Report 2006 50 No. RR-14 1 16 23515099
44. Testing for HIV: concise guidance. Palfreeman A, Clin Med 2009 9 5 471 476 19886111
45. HIV testing among pregnant women-United States and Canada, 1998-2001. Centers for Disease Control and Prevention, MMWR-Morbidity & Mortality Weekly Report 2002 51 1013 1016 23515099
46. Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent. Stanley B, Fraser J, Cox NH, BMJ 2003 326 7400 1174 10.1136/bmj.326.7400.1174 12775616 (Pubitemid 36649051)
47. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. Marks G, J Acquir Immune Defic Syndr 2005 39 4 446 453 10.1097/01.qai.0000151079.33935.79 16010168 (Pubitemid 41003791)
48. Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Vernazza P, Bull Med Suisses 2008 89 165 169
49. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. Castilla J, J Acquir Immune Defic Syndr 2005 40 1 96 101 10.1097/01.qai.0000157389.78374.45 16123689 (Pubitemid 41233212)